Artivion | CRY - Ebitda

Aktienkurs
35.29
Täglich Wechseln
-1.10 -3.02%
Monatlich
-8.46%
Jährlich
45.53%
Q1 Prognose
35.04




Ebitda Veränderung Datum
Abbott USD 3.09B 44M 2025-09
Accuray USD -685K 900K 2024-09
AngioDynamics USD 5.94M 3.78M 2025-09
Artivion USD 22.72M 1.84M 2025-12
AtriCure USD 19.86M 2.06M 2025-12
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.37B 1000K 2025-09
Edwards Lifesciences USD 464.3M 4.7M 2025-09
Integra LifeSciences USD 104.21M 25.76M 2025-12
J&J USD 9.52B 389M 2025-09
Mesa Laboratories USD 9.58M 1.47M 2024-09
Orthofix International USD 27.88M 2.77M 2025-12
Pfizer USD 6.08B 351M 2025-09
ResMed USD 547.48M 27.46M 2025-12
Stryker USD 1.67B 206M 2025-09
Surmodics USD 1.53M 485K 2024-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Terumo JPY 69.99B 3.22B 2025-12
Trinity Biotech USD -9.6M 7.64M 2024-12